US EditionPublished • loading... • Updated
Obesity recognition ‘going in right direction’ amid GLP-1 revolution, but obstacles remain
Summary by The Hill
1 Articles
1 Articles
Obesity recognition ‘going in right direction’ amid GLP-1 revolution, but obstacles remain
ATLANTA — The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of treating it also puts the health care system in a bind. Dr. Scott Kahan, director of the National Center for Weight & Wellness and a faculty member at the Johns Hopkins Bloomberg…
·Washington, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
